Position in INVA
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$627,841
+$89,191 QoQ
Shares Held
26,946
0.0% QoQ
Ownership
0.037%
of shares outstanding
% of Portfolio
0.37%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in INVA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026VIRTUS ADVISERS, LLC holds $6,375,075 across 18 Biotechnology names. INVA ranks #3 (9.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ACAD |
Acadia Pharmaceuticals Inc
|
42,974 | $956,600 | |
| 2 | GMAB |
Genmab A/S
|
30,830 | $827,168 | |
| 3 | INVA |
Innoviva, Inc.
This page
|
26,946 | $627,841 | |
| 4 | SRPT |
Sarepta Therapeutics, Inc.
|
25,800 | $561,408 | |
| 5 | EXEL |
Exelixis, Inc.
|
13,000 | $557,570 | |
| 6 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
8,805 | $552,073 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
15,850 | $439,045 | |
| 8 | HRMY |
Harmony Biosciences Holdings, Inc.
|
15,399 | $431,325 |
All Filings in INVA
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $627,841 | 26,946 | Shares | Other | 2026-05-14 | |
| 2025-12-31 | $538,650 | 26,946 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $491,764 | 26,946 | Shares | Other | 2026-02-13 | |
| 2025-06-30 | $541,345 | 26,946 | Shares | Other | 2026-02-13 | |
| 2025-03-31 | $488,530 | 26,946 | Shares | Other | 2026-02-13 | |
| No filing history on record for this holder in this stock. | ||||||